Matrix metalloproteinases in multiple sclerosis - Targets of therapy or markers of injury?

被引：16

作者：

Bever, CT

Rosenberg, GA

机构：

[1] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA

[2] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA

[3] VA Maryland Hlth Care Syst, Serv Neurol, Baltimore, MD USA

[4] VA Maryland Hlth Care Syst, Res Serv, Baltimore, MD USA

[5] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA

[6] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA

[7] Univ New Mexico, Sch Med, Dept Cell Biol & Physiol, Albuquerque, NM 87131 USA

来源：

NEUROLOGY | 1999年 / 53卷 / 07期

关键词：

D O I：

10.1212/WNL.53.7.1380

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1380 / 1381

页数：2

共 12 条

[11] Changes of serum sICAM-1 and MMP-9 induced by rIFNβ-1b treatment in relapsing-remitting MS [J].

Trojano, M ;

Avolio, C ;

Liuzzi, GM ;

Ruggieri, M ;

Defazio, G ;

Liguori, M ;

Santacroce, MP ;

Paolicelli, D ;

Giuliani, F ;

Riccio, P ;

Livrea, P .

NEUROLOGY, 1999, 53 (07) :1402-1408

[12] Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis [J].

Waubant, E ;

Goodkin, DE ;

Gee, L ;

Bacchetti, P ;

Sloan, R ;

Stewart, T ;

Andersson, PB ;

Stabler, G ;

Miller, K .

NEUROLOGY, 1999, 53 (07) :1397-1401

← 1 2 →